Both in Pharmaceuticals
AN2 Therapeutics vs Oramed Pharmaceuticals
Over the past year ANTX returned +318.9% and ORMP returned +76.9%; their daily moves had a correlation of 0.07.
ANTX +318.9% ORMP +76.9%Growth of $1, one year, split-adjusted
| Metric | ANTX | ORMP |
|---|---|---|
| Price | $5.32 | $4.67 |
| Market cap | $200.8M | $194.3M |
| Today | +4.52% | −0.43% |
| 1 month | −4.1% | −7.0% |
| 6 months | +55.6% | +37.4% |
| Year to date | +366.7% | +63.9% |
| 1 year | +314.0% | +73.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.1× |
| Price / sales | — | — |
| Net cash | $78.4M | $50.6M |
| Dividend yield | — | 5.35% |
| Volatility (60d) | 52.9% | 40.1% |
| Short % of float | 9.6% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).